Skip to main content
Signal8

Brewer Joanna Elizabeth

SEC insider (Form 3/4/5 filer). CIK 0001923834. Chief Scientific Officer at Adaptimmune Therapeutics PLC (ADAP). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 20, 2025. Located in ABINGDON, X0.

Companies Brewer Joanna Elizabeth has filed insider reports for

  • Adaptimmune Therapeutics PLC (ADAP): Officer, Chief Scientific Officer
Brewer Joanna Elizabeth profile photo

Brewer Joanna Elizabeth

CIK: 0001923834

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Adaptimmune Therapeutics PLC logo
ADAP

Adaptimmune Therapeutics PLC

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Adaptimmune Therapeutics PLC logo
    ADAP

    Adaptimmune Therapeutics PLC

    Feb 20, 2025
    Award

    Option to purchase Ordinary Shares

    Direct
    1.6M shares-
  • Adaptimmune Therapeutics PLC logo
    ADAP

    Adaptimmune Therapeutics PLC

    Feb 20, 2025
    Award

    Option to purchase Ordinary Shares

    Direct
    1.1M shares-

1-2 of 2